Neoadjuvant Tamoxifen in Locally Advanced Breast Cancer in a Low/Middle Income Country
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
This study evaluates the feasibility and efficacy of neoadjuvant tamoxifen for patients with
locally advanced hormone receptor positive breast cancer in a low/middle income country.
Phase:
Phase 2
Details
Lead Sponsor:
Vanderbilt University
Collaborators:
Instituto National de Cancerologia, Guatemala Washington University School of Medicine